Приказ основних података о документу

Quantification of Antidepressant and Antipsychotic Exposure Increase Caused by CYP2C19 and CYP2D6 Intermediate and Poor Metabolizer Status

dc.creatorMilosavljević, Filip
dc.creatorBukvić, Nikola
dc.creatorPešić, Vesna
dc.creatorPavlović, Zorana
dc.creatorMiljević, Čedo
dc.creatorMolden, Espen
dc.creatorIngelman-Sundberg, Magnus
dc.creatorJukić, Marin
dc.date.accessioned2023-05-25T10:07:18Z
dc.date.available2023-05-25T10:07:18Z
dc.date.issued2019
dc.identifier.issn0893-133X
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/4752
dc.language.isoensr
dc.publisherSpringer Naturesr
dc.rightsrestrictedAccesssr
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceNeuropsychopharmacologysr
dc.subjectAntidepressantsr
dc.subjectAntipsychoticsr
dc.subjectPharmacokineticssr
dc.subjectPharmacogeneticssr
dc.subjectPrecision Medicine Neuropsychiatric Diseasessr
dc.titleQuantification of Antidepressant and Antipsychotic Exposure Increase Caused by CYP2C19 and CYP2D6 Intermediate and Poor Metabolizer Statussr
dc.typeconferenceObjectsr
dc.rights.licenseARRsr
dc.citation.issue44
dc.citation.spage139
dc.description.otherACNP 58th Annual Meeting: Poster Sessionsr
dc.identifier.wos000509665600273
dc.identifier.doi10.1038/s41386-019-0545-y
dc.identifier.pmid31801976
dc.type.versionpublishedVersionsr


Документи

Thumbnail
Име:
Quantification_of_Antidepressa ...
Величина:
133.7Kb
Формат:
PDF
Отварање

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу